Ads
related to: merck- Order-To-Cash Services
We provide valuable expertise and
a 3PL infrastructure. Learn more.
- Quick Pricing
We answer requests within 24 hours.
Exceptional service
- Knowledgeable Experts
Understand the complexity.
We offer true partnership.
- Reliable & Experienced
Integrated logistics solutions
designed to support pharma industry
- Building Trust Since 1997
Tailored logistics solutions.
We increase supply chain efficiency
- Title Model Solutions
We take title of the product on
behalf of the manufacturer.
- Order-To-Cash Services
Search results
Merck Rides Keytruda To A Beat-And-Raise Despite Diabetes Pullback
Investor's Business Daily· 55 minutes agoMerck's bread-and-butter cancer drug grew by double digits again in the first quarter.
Merck hikes outlook for 2024 as Q1 print beats analyst estimates By Investing.com
Investing.com· 35 minutes agoMerck (MRK) saw its shares climb 1.5% in premarket trading Thursday after the pharma company hiked...
Merck raises 2024 profit forecast on strong sales of cancer drug Keytruda By Reuters
Investing.com· 52 minutes agoThe New Jersey-based drugmaker said it expected earnings of $8.53 and $8.65 per share, up from its...
Merck’s first-quarter results beat expectations amid healthy vaccine-sales growth
Market Watch· 54 minutes agoMerck & Co. Inc. on Thursday reported first-quarter results that beat analysts’ expectations amid...
Merck&Co earnings beat by $0.14, revenue topped estimates
Investing.com· 6 hours agoMerck&Co earnings beat by $0.14, revenue topped estimates
Merck: Q1 Earnings Snapshot
Houston Chronicle· 40 minutes agoRAHWAY, N.J. (AP) — Merck & Co. (MRK) on Thursday reported first-quarter earnings of $4.76 billion. On a per-share basis, the Rahway, New Jersey-based company said it had ...
Merck beats earnings expectations, raises outlook on strong Keytruda and vaccine sales
CNBC· 53 minutes agoMerck on Thursday reported first-quarter revenue and adjusted earnings that topped expectations as...
Merck Raises Forecast as Sales of Its Cancer Immune Therapy Soar
Bloomberg· 54 minutes agoMerck & Co. raised its annual profit and revenue forecast as the blockbuster cancer drug Keytruda...
Merck to Report Earnings One Month After Major Drug Approval. What Investors Are Watching.
Barrons.com· 15 hours agoFEATURE Merck is set to announce its first quarter financial results on Thursday, a month after the...
Merck Earnings Preview: Strong quarter expectations on the back of core products' growth
Seeking Alpha· 21 hours agoMerck (NYSE:MRK) is scheduled to announce Q1 earnings results on Thursday, April 25th, before market...
